Protalix Biotherapeutics logo

Protalix Biotherapeutics Share Price (NYSE: PLX)

$1.53

-0.01

(-0.65%)

Live

Last updated on

Check the interactive Protalix Biotherapeutics Stock chart to analyse performance

Protalix Biotherapeutics Inc Key Stats

Check Protalix Biotherapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.54
Open
$1.5
Market Capitalization
$117.8M
Today's Volume
$644.4K
Revenue TTM
$61.9M
EBITDA
$9.6M
Earnings Per Share (EPS)
$0.09
PE Ratio
16.44
Profit Margin
10.13%
Quarterly Earnings Growth YOY
-0.39%
Return On Equity TTM
15.99%

Stock Returns calculator for Protalix Biotherapeutics Stock including INR - Dollar returns

The Protalix Biotherapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Protalix Biotherapeutics investment value today

Current value as on today

₹1,62,999

Returns

₹62,999

(+63%)

Returns from Protalix Biotherapeutics Stock

₹59,375 (+59.38%)

Dollar Returns*

₹3,624 (+3.62%)

Indian investors sentiment towards Protalix Biotherapeutics Stock

-61%

Period: Jul 19, 2025 to Aug 18, 2025. Change in 30 Days versus previous period

Search interest for Protalix Biotherapeutics Stock from India on INDmoney has decreased by -61% in the last 30 days, reflecting a downward trend in search activity.

Analyst Recommendation on Protalix Biotherapeutics Stock

Rating
Trend

Buy

    80%Buy

    20%Hold

    0%Sell

Based on 5 Wall street analysts offering stock ratings for Protalix Biotherapeutics(by analysts ranked 0 to 5 stars)

Protalix Biotherapeutics Share Price Target

What analysts predicted

Upside of 815.03%

Target:

$14.00

Current:

$1.53

Protalix Biotherapeutics share price target is $14.00, a slight Upside of 815.03% compared to current price of $1.53 as per analysts' prediction.

Protalix Biotherapeutics Stock Insights

  • Price Movement

    In the last 7 days, PLX stock has moved down by -5.8%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 10.11M → 15.65M (in $), with an average increase of 35.4% per quarter
  • Increasing Net Profit

    Netprofit is up for the last 2 quarters, -3.61M → 164.0K (in $), with an average increase of 2306.7% per quarter
  • PLX vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 66.4% return, outperforming this stock by 5.5%
  • Price to Sales

    ForPLX every $1 of sales, investors are willing to pay $1.9, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $24.0 for every $1 of sales.

Protalix Biotherapeutics Inc Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$53.4M
↓ 18.47%
Net Income
$2.9M
↓ 64.73%
Net Profit Margin
5.49%
↓ 7.2%

Protalix Biotherapeutics Technicals Summary

Sell

Neutral

Buy

Protalix Biotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Protalix Biotherapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Protalix Biotherapeutics Inc logo
1.64%
-38.69%
60.94%
-2.83%
-2.83%
Regeneron Pharmaceuticals, Inc. logo
5.3%
-15.53%
-52.01%
-6.15%
-6.88%
Beone Medicines Ltd logo
9.32%
34.03%
65.78%
84.48%
35.61%
Vertex Pharmaceuticals Incorporated logo
-14.97%
-15.63%
-20.12%
32.68%
43.64%
Alnylam Pharmaceuticals, Inc. logo
42.53%
82.74%
66.44%
109.65%
235.02%

About Protalix Biotherapeutics Inc

Protalix BioTherapeutics, Inc., a biopharmaceutical company, engages in the development, production, and commercialization of recombinant therapeutic proteins based on the ProCellEx plant cell-based protein expression system. The company offers Elelyso for the treatment of Gaucher disease; and Elfabrio for the treatment of adult patients with a confirmed diagnosis of Fabry disease. It is also developing PRX-115, a plant cell expressed recombinant PEGylated Uricase, which is in Phase 2 trial for the treatment of gout; and PRX-119, a plant cell expressed PEGylated recombinant human DNase I product candidate for the treatment of neutrophil extracellular traps diseases. The company has agreements and partnerships with Pfizer; Fundação Oswaldo Cruz; and Chiesi Farmaceutici S.p.A. It operates in the United States, Australia, Canada, Israel, Brazil, Russia, and Turkey. The company is headquartered in Hackensack. New Jersey.
Organization
Protalix Biotherapeutics
Employees
213
CEO
Mr. Dror Bashan
Industry
Health Services

Key Management of Protalix Biotherapeutics Inc

NameTitle
Mr. Dror Bashan
President, CEO & Director
Mr. Eyal Rubin M.B.A.
Senior VP, CFO, Treasurer & Corporate Secretary
Mr. Yaron Naos B.Sc., MBA
Senior Vice President of Operations
Ms. Yael Fellous
Vice President of Human Resources

Important FAQs about investing in PLX Stock from India :

What is Protalix Biotherapeutics share price today?

Protalix Biotherapeutics share price today is $1.53 as on . Protalix Biotherapeutics share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Protalix Biotherapeutics share?

Protalix Biotherapeutics share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Protalix Biotherapeutics stock price today i.e. is trending at $1.53, lower by 50.65% versus the 52 week high.

How to invest in Protalix Biotherapeutics Stock (PLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Protalix Biotherapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protalix Biotherapeutics Shares that will get you 0.9804 shares as per Protalix Biotherapeutics share price of $1.53 per share as on August 19, 2025 at 11:41 PM IST.

What is the minimum amount required to buy Protalix Biotherapeutics Stock (PLX) from India?

Indian investors can start investing in Protalix Biotherapeutics (PLX) shares with as little as ₹86.938 or $1 (as of August 19, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹869.38 in Protalix Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on August 19, 2025). Based on Protalix Biotherapeutics share’s latest price of $1.53 as on August 19, 2025 at 11:41 PM IST, you will get 6.5359 shares of Protalix Biotherapeutics. Learn more about fractional shares .

What are the returns that Protalix Biotherapeutics has given to Indian investors in the last 5 years?

Protalix Biotherapeutics stock has given -2.83% share price returns and 16.15% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your US Stock Investments?